Amy Mergen is a big-picture, around for the long-haul, never give up girl. Amy has been with FIS for 23 years, she is the chief of staff to the president and CEO, which involves a lot of project management, a skill she made use of during her cancer treatment. Four years ago, at the age Read More >>
TapImmune, Inc. (NASDAQ: TPIV), a clinical- stage immuno-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer and metastatic disease today announced the opening of its Phase 2 company-sponsored ovarian cancer study in platinum-sensitive ovarian cancer patients.
Read More »
Do the names of others motivate you to the finish line? Are you running for someone you love? Do you have someone special to thank for donating to your fundraising efforts? Don’t forget to order your custom back bibs! Each bib is only $6.99, and a percentage of the proceeds will go to The DONNA Foundation. These pre-ordered bibs will be delivered to your door by the great folks at YourBibs.com. The deadline to order is January 31 at 5:00 p.m. EST to ensure delivery by race day. Order yours today »
She’s traveled the world and become one of the nation’s most successful travel agents, but Mara Hargarther considers a three-mile stretch in downtown Jacksonville, Florida her most memorable journey, as she is a breast cancer survivor. The New York native worked on Wall Street as a financial executive until she married Tom and left to […]
Hawaiin, Louel Larkin knows everyone thinks of Hawaii and Hawaiians as healthy, fruit-eating beach goers living in paradise, but Louel was diagnosed with breast cancer in May 2001. She is speaking up, because she wants women to be careful of hormone therapy. “The polka dots on my right breast x-ray bothered the radiologist,” says Louel, […]
Closer to the Finish! DONNA partner TapImmune announced that its common stock has been approved to begin trading on The Nasdaq Capital Market. The company’s common stock will begin trading under the symbol “TPIV” at the opening of trading on Tuesday, November 8, 2016.
Closer to the Finish! DONNA partner TapImmune announces the commercialization pathway for its HER2neu Vaccine and the initiation of company-sponsored Phase 2 Clinical Trials that will start early 2017. In a Phase I clinical trial on the four Class II antigens in HER2neu breast cancer patients performed at the Mayo Clinic.
In whatever way you choose to #BeTheFINISH, your efforts are making a difference. All proceeds of DONNA Marathon Weekend support The DONNA Foundation for breast cancer research and care. So where does it all go?
Check out The DONNA Foundation – by the numbers »
Pave the way to Finish Breast Cancer, brick by brick. Announcing your opportunity to etch your name into history in Oceanfront Park in Jacksonville Beach by purchasing a commemorative brick. Leave your legacy, and celebrate those impacted by breast cancer with your own personalized brick.
Leave your legacy »
Closer to the Finish! DONNA partner TapImmune issued an update to shareholders September 6 announcing the commencement of enrollment of patients in Q4 2016 for the Phase 2 study of TPIV 200 in the treatment of triple negative breast cancer.
David Garrard, former QB1 for the Jacksonville Jaguars, lost his mom to breast cancer when he was only 16. “I was only 14 when she was diagnosed, and I had never heard of cancer. I certainly had no idea of the pain it caused,” says Garrard. “I had an older brother and a little sister, […]
In 2006 during a routine mammogram, Patty was diagnosed with DCIS. She elected to have a lumpectomy. During her postoperative checkup another spot was found, so she immediately had a 2nd lumpectomy, followed by 6 weeks of radiation. Very quickly she got involved with 26.2 with DONNA, running the first half marathon and volunteering in 2008. She now looks forward to celebrating 10 years with 26.2 in 2017.
DONNA partner TapImmune announced its plans to enter into definitive agreements to raise aggregate gross proceeds of approximately $8.5 million from an approximately $2.5 million private placement transaction with new investors and the exercise of certain outstanding warrants from existing investors that will result in gross proceeds of $6 million.
Mary lives her life through her Christian faith, dedication to her family and through service to others. She is an alumni of the University of Tennessee, Knoxville, and her family are avid Tennessee fans. They moved to St Augustine in 2000 and in March this year they celebrated their 25th wedding anniversary. They have two daughters, […]
The DONNA Foundation has a bold vision to finish breast cancer. To achieve this vision, it will take support from everyone. Runners, volunteers, donors and sponsors. Individuals and companies – large and small. We are excited to welcome Turner Pest Control as a sponsor of our upcoming THE PLAYERS DONNA 5K, and share their story and that of their employee and long time DONNA volunteer Patrick Sheehan.
I wish I could bottle it, this feeling I have right now. One of our runners wrote this morning to say she still hasn’t stopped smiling. I haven’t either. The love, support, and enthusiasm that this community shared with runners from all over the world Valentine’s weekend was nothing short of astounding.
DONNA partner TapImmune announced a major milestone of dosing its first patient in a Phase 2 trial for triple negative breast cancer with its cancer vaccine TPIV 200. The randomized, open label Phase 2 study is expected to enroll a total of 80 subjects. Go Team Go!
Olympian and DONNA ‘Streaker’ Joan Benoit-Samuelson offers her advice for a fast finish at the 9th Annual DONNA Marathon Weekend. An Olympian well known in the running world, Samuelson won the Boston Marathon in 1979 and again in 1983. She won gold at the Olympics’ first women’s marathon in 1984 […]